{"id":"W4386271173","doi":"10.1016/s2152-2650(23)01206-5","title":"MDS-641 Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients: Interim Safety Analysis","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta Hospital; London Health Sciences Centre","funders":"","keywords":"Decitabine; Myelodysplastic syndromes; Interim analysis; Medicine; Interim; Oncology; Internal medicine; Randomized controlled trial; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001968134,0.002016699,0.002570537,0.0005282477,0.0003861087,0.0009896627,0.0008206008,0.001106499,0.007137844],"category_scores_gemma":[0.001492171,0.0007452776,0.001791555,0.0004099729,0.000991427,0.000704552,0.000447862,0.00293637,0.001396029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001213011,"about_ca_system_score_gemma":0.001683016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009914502,"about_ca_topic_score_gemma":0.002834569,"domain_scores_codex":[0.9994185,0.0003661104,0.00002103651,0.00007613092,0.00003829509,0.00007999777],"domain_scores_gemma":[0.9992197,0.000169289,0.0002289379,0.00008654024,0.0000487476,0.0002468808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9615898,0.004715102,0.001947403,0.0003806388,0.001142965,0.00006621974,0.00005004605,0.001187506,0.006751869,0.0001986167,0.002183662,0.01978616],"study_design_scores_gemma":[0.9340757,0.0568795,0.004618159,0.00003628734,0.0006561443,0.00007163042,0.00001939419,0.0007006993,0.0009161911,0.0003239099,0.001681791,0.0000205096],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841251,0.002534796,0.001029378,0.0007481864,0.0002116032,0.003311537,0.004372679,0.0002649824,0.003401606],"genre_scores_gemma":[0.9746743,0.001845052,0.00312856,0.001344963,0.000242781,0.00429375,0.007152503,0.00008862009,0.007229392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007137844,"threshold_uncertainty_score":0.02387846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0443610251947838,"score_gpt":0.3911708461793387,"score_spread":0.3468098209845549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}